Status:
RECRUITING
Determining the Frequency of Occurrence and Defining the Most Appropriate Screening Test for Anal Intraepithelial Neoplasia (AIN) in Patients With Human Papillomavirus (HPV) Related Gynecological Diseases.
Lead Sponsor:
PCK Marine Hospital in Gdynia
Collaborating Sponsors:
Medical University of Gdansk
National Science Centre, Poland
Conditions:
HPV-Related Carcinoma
HPV Infection
Eligibility:
FEMALE
Phase:
NA
Brief Summary
The primary aim of the study is to determine the total risk of AIN in group of HPV-RGD survivors and additionally to establish an exact risk for each of HPV-related gynecological precancers/cancers. M...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- HPV related gynecological disease confirmed in histo-pathological examination
- the posibility to obtain material from gynecological organ and from anal canal
Exclusion
Key Trial Info
Start Date :
January 13 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2027
Estimated Enrollment :
248 Patients enrolled
Trial Details
Trial ID
NCT06574087
Start Date
January 13 2023
End Date
January 1 2027
Last Update
July 23 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
PCK Marine Hospital in Gdynia
Gdynia, Pomeranian Voivodeship, Poland, 81-519